D-MARKET ELECTRONIC SERV-ADR (HEPS)

US23292B1044 - ADR

3.18  -0.05 (-1.55%)

After market: 3.25 +0.07 (+2.2%)

Fundamental Rating

4

HEPS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 32 industry peers in the Broadline Retail industry. HEPS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. HEPS shows excellent growth, but is valued quite expensive already.



1

1. Profitability

1.1 Basic Checks

HEPS had negative earnings in the past year.
In the past year HEPS had a positive cash flow from operations.
In the past 5 years HEPS reported 4 times negative net income.
Of the past 5 years HEPS 4 years had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -6.54%, HEPS is doing worse than 70.97% of the companies in the same industry.
HEPS has a worse Return On Equity (-43.66%) than 70.97% of its industry peers.
Industry RankSector Rank
ROA -6.54%
ROE -43.66%
ROIC N/A
ROA(3y)-11.34%
ROA(5y)-14.4%
ROE(3y)-45.04%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 35.27%, HEPS is not doing good in the industry: 67.74% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of HEPS has grown nicely.
The Profit Margin and Operating Margin are not available for HEPS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 35.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.14%
GM growth 5Y6.31%

5

2. Health

2.1 Basic Checks

HEPS does not have a ROIC to compare to the WACC, probably because it is not profitable.
HEPS has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, HEPS has less shares outstanding
Compared to 1 year ago, HEPS has an improved debt to assets ratio.

2.2 Solvency

HEPS has an Altman-Z score of 2.67. This is not the best score and indicates that HEPS is in the grey zone with still only limited risk for bankruptcy at the moment.
HEPS has a Altman-Z score of 2.67. This is in the better half of the industry: HEPS outperforms 61.29% of its industry peers.
HEPS has a debt to FCF ratio of 0.35. This is a very positive value and a sign of high solvency as it would only need 0.35 years to pay back of all of its debts.
HEPS has a better Debt to FCF ratio (0.35) than 90.32% of its industry peers.
A Debt/Equity ratio of 0.44 indicates that HEPS is not too dependend on debt financing.
The Debt to Equity ratio of HEPS (0.44) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 0.35
Altman-Z 2.67
ROIC/WACCN/A
WACC28.9%

2.3 Liquidity

HEPS has a Current Ratio of 1.02. This is a normal value and indicates that HEPS is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.02, HEPS is not doing good in the industry: 90.32% of the companies in the same industry are doing better.
HEPS has a Quick Ratio of 1.02. This is a bad value and indicates that HEPS is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of HEPS (0.66) is worse than 80.65% of its industry peers.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 0.66

7

3. Growth

3.1 Past

HEPS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -573.58%.
Looking at the last year, HEPS shows a very strong growth in Revenue. The Revenue has grown by 149.58%.
Measured over the past years, HEPS shows a very strong growth in Revenue. The Revenue has been growing by 78.63% on average per year.
EPS 1Y (TTM)-573.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-62.71%
Revenue 1Y (TTM)149.58%
Revenue growth 3Y77.34%
Revenue growth 5Y78.63%
Sales Q2Q%57.93%

3.2 Future

HEPS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 31.45% yearly.
Based on estimates for the next years, HEPS will show a very strong growth in Revenue. The Revenue will grow by 46.89% on average per year.
EPS Next Y-116.09%
EPS Next 2Y19.31%
EPS Next 3Y31.45%
EPS Next 5YN/A
Revenue Next Year76.02%
Revenue Next 2Y57.61%
Revenue Next 3Y46.89%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

3

4. Valuation

4.1 Price/Earnings Ratio

HEPS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 27.23, HEPS can be considered very expensive at the moment.
HEPS's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.67, HEPS is valued at the same level.
Industry RankSector Rank
PE N/A
Fwd PE 27.23

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HEPS is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, HEPS is valued cheaply inside the industry as 90.32% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.36
EV/EBITDA 20.7

4.3 Compensation for Growth

HEPS's earnings are expected to grow with 31.45% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.31%
EPS Next 3Y31.45%

0

5. Dividend

5.1 Amount

HEPS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

D-MARKET ELECTRONIC SERV-ADR

NASDAQ:HEPS (1/6/2025, 5:20:01 PM)

After market: 3.25 +0.07 (+2.2%)

3.18

-0.05 (-1.55%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)12-10 2024-12-10/bmo
Earnings (Next)N/A N/A
Inst Owners7.07%
Inst Owner Change0.03%
Ins Owners60.85%
Ins Owner ChangeN/A
Market Cap1.02B
Analysts84.44
Price Target3.98 (25.16%)
Short Float %0.7%
Short Ratio0.22
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.41%
PT rev (3m)5.41%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-201.7%
EPS NY rev (3m)-112.35%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.85%
Revenue NY rev (3m)0.04%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 27.23
P/S 0.58
P/FCF 7.36
P/OCF 5.45
P/B 9.86
P/tB 39.48
EV/EBITDA 20.7
EPS(TTM)-0.14
EYN/A
EPS(NY)0.12
Fwd EY3.67%
FCF(TTM)0.43
FCFY13.6%
OCF(TTM)0.58
OCFY18.36%
SpS5.53
BVpS0.32
TBVpS0.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.54%
ROE -43.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 35.27%
FCFM 7.82%
ROA(3y)-11.34%
ROA(5y)-14.4%
ROE(3y)-45.04%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.14%
GM growth 5Y6.31%
F-Score4
Asset Turnover2.57
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 0.35
Debt/EBITDA 1
Cap/Depr 94.74%
Cap/Sales 2.74%
Interest Coverage N/A
Cash Conversion 413.77%
Profit Quality N/A
Current Ratio 1.02
Quick Ratio 0.66
Altman-Z 2.67
F-Score4
WACC28.9%
ROIC/WACCN/A
Cap/Depr(3y)121.47%
Cap/Depr(5y)110.53%
Cap/Sales(3y)3.7%
Cap/Sales(5y)2.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-573.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-62.71%
EPS Next Y-116.09%
EPS Next 2Y19.31%
EPS Next 3Y31.45%
EPS Next 5YN/A
Revenue 1Y (TTM)149.58%
Revenue growth 3Y77.34%
Revenue growth 5Y78.63%
Sales Q2Q%57.93%
Revenue Next Year76.02%
Revenue Next 2Y57.61%
Revenue Next 3Y46.89%
Revenue Next 5YN/A
EBIT growth 1Y79.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year254.01%
EBIT Next 3Y96.59%
EBIT Next 5YN/A
FCF growth 1Y411.4%
FCF growth 3Y124.57%
FCF growth 5Y100.63%
OCF growth 1Y855.4%
OCF growth 3Y124.87%
OCF growth 5Y97.22%